Conclusion
As the popularity of COVID-19 continues to spread globally, we need to plan and prepare well. Obstetricians and gynaecologists will be at the forefront of special patient management, so we need to know more about the virology, epidemiology and clinical data of COVID-19. Learn from the past experience of SARS, understand the current epidemiological factors of COVID-19, master the knowledge of infection prevention and control, and do well in the treatment of infected patients on the premise of self-protection. Using a multidisciplinary team management approach, sharing data, knowledge and expertise are very important.
Author contributions Hongyuan Zhang and Wei Chen: Preparation, manuscript original writing. Yuanjing Hu: Supervision and manuscript review. Yingjun Zhu and Xu Chen: Edit and data collection.
Acknowledgements The authors are grateful to the staff of the Oncology, Obstetrics and emergency department at the Tianjin Central Gynecology and Obstetrics Hospital for their kind assistance and collaboration in data collection.
Disclosure of Interests The authors report no conflict of interests.
Details of ethics approval No ethics approval applicable for this commentary
Funding This work was supported by the Tian Jin Science Foundation of China under Grant 17JCYBJC26900.
REFERENCES
[1] Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020;382(10): 929-936.
[2] Wu F, Zhao S, Yu B, Chen YM, Wang W, Song AG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265-269.
[3] WHO. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). February, 2020.
[4] Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. New Engl J Med 2020;382(12):1177-1179.
[5] Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID‐19 infection in nine pregnant women: a retrospective review of medical records. The Lancet. 2020;395(10226): 809-815.
[6] Gagneur A, Dirson E, Audebert S, Vallet S, Quillien M, Baron R, et al. Vertical transmission of human coronavirus. Prospective pilot study. Pathol Biol (Paris). 2007;55(10):525-530.
[7] Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of chest CT and RT-PCR testing in Coronavirus Disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020; Feb 26:200642..
[8] Mair‐Jenkins J, Saavedra‐Campos M, Baillie JK, Cleary P, Khaw FM, Lim WS, et al. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta‐analysis. J Infect Dis. 2015;211(1):80‐90.
[9] Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269-271.
[10] Weinberger S, Weiss S, Cohen W, Weiss J, Johnson T. Pregnancy and The Lung. American Review of Respiratory Disease. 1980;121(3):559-581.